{
    "organizations": [],
    "uuid": "0a4ed83d7706f929e2ce020c815b270e4f6a0d7b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-crispr-therapeutics-qtrly-collabor/brief-crispr-therapeutics-qtrly-collaboration-revenue-32-3-mln-idUSASB0C9KY",
    "ord_in_thread": 0,
    "title": "BRIEF-Crispr Therapeutics Qtrly ‍​collaboration Revenue $32.3 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 8 (Reuters) - Crispr Therapeutics Ag:\n* CRISPR THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS\n* CRISPR THERAPEUTICS AG - QTRLY ‍​COLLABORATION REVENUE $32.3 MILLION VERSUS $2.3 MILLION Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-03-09T05:42:00.000+02:00",
    "crawled": "2018-03-09T14:33:17.013+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "crispr",
        "therapeutic",
        "ag",
        "crispr",
        "therapeutic",
        "provides",
        "business",
        "update",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "crispr",
        "therapeutic",
        "ag",
        "qtrly",
        "revenue",
        "million",
        "versus",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}